OpenAlex
Works that cite this article, indexed by OpenAlex.
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
Cochrane Database of Systematic Reviews 2020(10) (2020)
Edmund Y. M. Chung; Marinella Ruospo; Patrizia Natale; Davide Bolignano; Sankar Dass Navaneethan; Suetonia C. Palmer; Giovanni FM Strippoli
Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
Journal of Diabetes Investigation 8(4) (2017)
Lijing Sun; Yanni Sun; Jianping Shan; Gengru Jiang
Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
American Journal of Cardiovascular Drugs 19(3) (2019)
Yanhuan Feng; Rongshuang Huang; Janet Kavanagh; Lingzhi Li; Xiaoxi Zeng; Yi Li; Ping Fu
Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
International Urology and Nephrology 51(4) (2019)
Dan Feng Dong; Tingting Fan; Yingshi Ji; Jinyu Yu; Shan Wu; Li Zhang
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Frontiers in Pharmacology 12 (2021)
Daiji Kawanami; Yuichi Takashi; Yoshimi Muta; Naoki Oda; Dai Nagata; Hiroyuki Takahashi; Makito Tanabe
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Pharmaceuticals 14(6) (2021)
Nina Vodošek Hojs; Sebastjan Bevc; Robert Ekart; Nejc Piko; Tadej Petreski; Radovan Hojs
Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
Journal of Diabetes Research 2015 (2015)
Songyan Wang; Bing Li; Chun Guang Li; Wenpeng Cui; Lining Miao
Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
Frontiers in Physiology 12 (2022)
Aneesh Dhore-Patil; Tariq Thannoun; Rohan Samson; Thierry H. Le Jemtel
Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease
Drug Delivery 30(1) (2022)
Xian Chen; Wenni Dai; Hao Li; Zhe Yan; Zhiwen Liu; Liyu He
The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy
Current Clinical Pharmacology 14(2) (2018)
Luxitaa Goenka; R Padmanaban; Melvin George
Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: a randomized controlled trial in a sub-Saharan African population
BMC Research Notes 9(1) (2016)
Romance Nguetse Djoumessi; Jean Jacques Noubiap; François Folefack Kaze; Mickael Essouma; Alain Ménanga; André Pascal Kengne; Jean Claude Mbanya; Eugène Sobngwi
Development, optimization, and assessment of losartan nano-bilosomes to mitigate diabetes-induced microvascular complications in Sprague Dawley rats
Journal of Drug Delivery Science and Technology 92 (2023)
Mona K.E. Qushawy; Ghareb M. Soliman; Yasmin Ismail Mortagi; Mohamed El‐Sherbiny; Nehal Mohsen Elsherbiny
Serum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis
American Journal of Health-System Pharmacy 78(24) (2021)
Lorenzo Villa Zapata; Briggs Carhart; John R. Horn; Philip D. Hansten; Vignesh Subbian; Sheila M. Gephart; Malinda Sunnita Tan; Andrew V. Romero; Daniel C. Malone
Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome
Journal of Clinical Medicine 10(13) (2021)
Diana Rubel; Yanqin Zhang; Nenja Sowa; Rainer Girgert; Oliver Groß
Drugs Targeting RAAS in the Treatment of Hypertension and Other Cardiovascular Diseases
Springer eBooks (2015)
Pitchai Balakumar; Gowraganahalli Jagadeesh
Reporting Quality Assessment of Randomized Controlled Trials Published in Nephrology Urology Monthly Journal
Nephro-Urology Monthly 7(4) (2015)
Alireza Mehrazmay; Alireza Karambakhsh; Mahmood Salesi
Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease
Medicine 100(35) (2021)
Mingming Zhao; Hua Qu; Rumeng Wang; Yi Yu; Meiying Chang; Sijia Ma; Hanwen Zhang; Yuejun Wang; Yu Zhang
Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33
Current Pharmaceutical Design 28(16) (2022)
Tina Ghaffari; Nariman Moradi; Elham Chamani; Zahra Ebadi; Reza Fadaei; Shahin Alizadeh‐Fanalou; Sahar Yarahmadi; Soudabeh Fallah
Effect of spironolactone on diabetic nephropathy in albino rats: ultrastructural and immunohistochemical study
International Journal of Scientific Reports 3(5) (2017)
Hassan M. Rezk; Mohamed El‐Sherbiny; Hoda Atef; Medhat Taha; Samar Hamdy; Raouf Fekry Bedir
Estudo de respostas fibróticas e apoptóticas em rins de ratos tratados com aldosterona
Digital Library of Theses and Dissertations (Universidade de São Paulo) (2017)
Paula Irusta Ferreira
Effect of spironolactone with angiotensin receptor blocker on albuminuria in type 2 diabetic patients with nephropathy
International Journal of Advances in Medicine 9(4) (2022)
Hasan Mahmud; A. N. M. Abdul Hai; Tofael Ahammod
Research Progress of Mineralocorticoid Receptor Antagonists on Diabetic Kidney Disease
Advances in Clinical Medicine 13(01) (2023)
璇 王